Quality of life at post‐treatment Indexed by self‐report measures of quality of life or functional disability · people with critical limb ischaemia due to non‐reconstructable peripheral arterial disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse effects Clinical assessment · people with critical limb ischaemia due to non‐reconstructable peripheral arterial disease
1 finding from 1 review
Mortality Clinical assessment · people with critical limb ischaemia due to non‐reconstructable peripheral arterial disease
1 finding from 1 review
Cardiovascular mortality · people with critical limb ischaemia
The review found no eligible studies for this question.
1 finding from 1 review
Amputation · people with critical limb ischaemia
PGE1 may leads to lower total amputations compared with ATP (low certainty).
1 finding from 1 review
Quality of life · people with critical limb ischaemia
The review found no eligible studies for this question.
1 finding from 1 review
Adverse event (participants) · people with critical limb ischaemia
PGE1 may leads to higher adverse event (participants) compared with ATP (low certainty).
1 finding from 1 review
Rest‐pain relief · people with critical limb ischaemia
1 finding from 1 review
Ulcer healing (complete) · people with critical limb ischaemia
PGE1 showed no clear difference in ulcer healing (complete) compared with ATP (low certainty).
1 finding from 1 review
Cardiovascular mortality · people with critical limb ischaemia
The review found no eligible studies for this question.
1 finding from 1 review
Amputation · people with critical limb ischaemia
The review found no eligible studies for this question.
1 finding from 1 review
Quality of life · people with critical limb ischaemia
The review found no eligible studies for this question.
1 finding from 1 review
Adverse events (participants) · people with critical limb ischaemia
PGE1 showed no clear difference in adverse events (participants) compared with inositol niacinate (low certainty).
1 finding from 1 review
Rest‐pain relief · people with critical limb ischaemia
PGE1 showed no clear difference in rest‐pain relief compared with inositol niacinate (low certainty).
1 finding from 1 review
Ulcer healing · people with critical limb ischaemia
PGE1 showed no clear difference in ulcer healing compared with inositol niacinate (low certainty).
1 finding from 1 review
Cardiovascular mortality · people with critical limb ischaemia
The review found no eligible studies for this question.
1 finding from 1 review
Amputation · people with critical limb ischaemia
Iloprost showed no clear difference in total amputations compared with PGE1 (low certainty).
1 finding from 1 review
Quality of life · people with critical limb ischaemia
The review found no eligible studies for this question.
1 finding from 1 review
Adverse events (participants) · people with critical limb ischaemia
Iloprost probably leads to higher adverse events (participants) compared with PGE1 (moderate certainty).
1 finding from 1 review
Rest‐pain relief · people with critical limb ischaemia
Iloprost showed no clear difference in rest‐pain relief compared with PGE1 (low certainty).
1 finding from 1 review